450 related articles for article (PubMed ID: 17461494)
1. Suppression of human colon tumor growth by adenoviral vector-mediated NK4 expression in an athymic mouse model.
Jie JZ; Wang JW; Qu JG; Hung T
World J Gastroenterol; 2007 Apr; 13(13):1938-46. PubMed ID: 17461494
[TBL] [Abstract][Full Text] [Related]
2. Suppression of metastasis of human pancreatic cancer to the liver by transportal injection of recombinant adenoviral NK4 in nude mice.
Murakami M; Nagai E; Mizumoto K; Saimura M; Ohuchida K; Inadome N; Matsumoto K; Nakamura T; Maemondo M; Nukiwa T; Tanaka M
Int J Cancer; 2005 Oct; 117(1):160-5. PubMed ID: 15880501
[TBL] [Abstract][Full Text] [Related]
3. Intraperitoneal injection of adenovirus-mediated NK4 gene suppresses peritoneal dissemination of pancreatic cancer cell line AsPC-1 in nude mice.
Saimura M; Nagai E; Mizumoto K; Maehara N; Okino H; Katano M; Matsumoto K; Nakamura T; Narumi K; Nukiwa T; Tanaka M
Cancer Gene Ther; 2002 Oct; 9(10):799-806. PubMed ID: 12224019
[TBL] [Abstract][Full Text] [Related]
4. Effects of adenoviral-mediated gene transduction of NK4 on proliferation, movement, and invasion of human colonic LS174T cancer cells in vitro.
Jie JZ; Wang JW; Qu JG; Wang W; Hung T
World J Gastroenterol; 2006 Jul; 12(25):3983-8. PubMed ID: 16810744
[TBL] [Abstract][Full Text] [Related]
5. [Effect of NK4 gene transfection on tumor growth of human pancreatic cancer xenograft in nude mice].
Lai RX; Zhang SN; Nakamura T; Yuan SZ
Ai Zheng; 2005 Oct; 24(10):1191-5. PubMed ID: 16219131
[TBL] [Abstract][Full Text] [Related]
6. Targeting angiogenesis and HGF function using an adenoviral vector expressing the HGF antagonist NK4 for cancer therapy.
Maemondo M; Narumi K; Saijo Y; Usui K; Tahara M; Tazawa R; Hagiwara K; Matsumoto K; Nakamura T; Nukiwa T
Mol Ther; 2002 Feb; 5(2):177-85. PubMed ID: 11829525
[TBL] [Abstract][Full Text] [Related]
7. Suppression of tumor growth, invasion and angiogenesis of human gastric cancer by adenovirus-mediated expression of NK4.
Heideman DA; van Beusechem VW; Bloemena E; Snijders PJ; Craanen ME; Offerhaus GJ; Derksen PW; de Bruin M; Witlox MA; Molenaar B; Meijer CJ; Gerritsen WR
J Gene Med; 2004 Mar; 6(3):317-27. PubMed ID: 15026993
[TBL] [Abstract][Full Text] [Related]
8. Blockage of HGF/c-Met system by gene therapy (adenovirus-mediated NK4 gene) suppresses hepatocellular carcinoma in mice.
Son G; Hirano T; Seki E; Iimuro Y; Nukiwa T; Matsumoto K; Nakamura T; Fujimoto J
J Hepatol; 2006 Nov; 45(5):688-95. PubMed ID: 16839638
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of tumorigenicity and metastasis of human bladder cancer growing in athymic mice by interferon-beta gene therapy results partially from various antiangiogenic effects including endothelial cell apoptosis.
Izawa JI; Sweeney P; Perrotte P; Kedar D; Dong Z; Slaton JW; Karashima T; Inoue K; Benedict WF; Dinney CP
Clin Cancer Res; 2002 Apr; 8(4):1258-70. PubMed ID: 11948141
[TBL] [Abstract][Full Text] [Related]
10. Mesenchymal stem cell-based NK4 gene therapy in nude mice bearing gastric cancer xenografts.
Zhu Y; Cheng M; Yang Z; Zeng CY; Chen J; Xie Y; Luo SW; Zhang KH; Zhou SF; Lu NH
Drug Des Devel Ther; 2014; 8():2449-62. PubMed ID: 25525335
[TBL] [Abstract][Full Text] [Related]
11. Peritumoral injection of adenovirus vector expressing NK4 combined with gemcitabine treatment suppresses growth and metastasis of human pancreatic cancer cells implanted orthotopically in nude mice and prolongs survival.
Ogura Y; Mizumoto K; Nagai E; Murakami M; Inadome N; Saimura M; Matsumoto K; Nakamura T; Maemondo M; Nukiwa T; Tanaka M
Cancer Gene Ther; 2006 May; 13(5):520-9. PubMed ID: 16341142
[TBL] [Abstract][Full Text] [Related]
12. Gallbladder cancer treatment using adenovirus expressing the HGF/NK4 gene in a peritoneal implantation model.
Tanaka T; Shimura H; Sasaki T; Narumi K; Maemondo M; Nukiwa T; Matsumoto K; Nakamura T; Ikeda S
Cancer Gene Ther; 2004 Jun; 11(6):431-40. PubMed ID: 15118756
[TBL] [Abstract][Full Text] [Related]
13. Gene transduction of NK4, HGF antagonist, inhibits in vitro invasion and in vivo growth of human pancreatic cancer.
Maehara N; Nagai E; Mizumoto K; Sato N; Matsumoto K; Nakamura T; Narumi K; Nukiwa T; Tanaka M
Clin Exp Metastasis; 2002; 19(5):417-26. PubMed ID: 12198770
[TBL] [Abstract][Full Text] [Related]
14. [Experimental study of NK4 gene targeted therapy mediated by human telomerase reverse transcriptase promoter for colon cancer].
Xu B; Xiao HQ; Zeng SQ; Huang GT; Liu ZB; Qian YJ; Li SH
Zhonghua Wei Chang Wai Ke Za Zhi; 2010 Nov; 13(11):851-4. PubMed ID: 21108065
[TBL] [Abstract][Full Text] [Related]
15. Systemic NK4 gene therapy inhibits tumor growth and metastasis of melanoma and lung carcinoma in syngeneic mouse tumor models.
Kishi Y; Kuba K; Nakamura T; Wen J; Suzuki Y; Mizuno S; Nukiwa T; Matsumoto K; Nakamura T
Cancer Sci; 2009 Jul; 100(7):1351-8. PubMed ID: 19438869
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of angiogenesis and HGF-cMET-elicited malignant processes in human hepatocellular carcinoma cells using adenoviral vector-mediated NK4 gene therapy.
Heideman DA; Overmeer RM; van Beusechem VW; Lamers WH; Hakvoort TB; Snijders PJ; Craanen ME; Offerhaus GJ; Meijer CJ; Gerritsen WR
Cancer Gene Ther; 2005 Dec; 12(12):954-62. PubMed ID: 15905856
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of colon cancer growth and metastasis by NK4 gene repetitive delivery in mice.
Wen J; Matsumoto K; Taniura N; Tomioka D; Nakamura T
Biochem Biophys Res Commun; 2007 Jun; 358(1):117-23. PubMed ID: 17467663
[TBL] [Abstract][Full Text] [Related]
18. Adenoviral-mediated gene transduction of the hepatocyte growth factor (HGF) antagonist, NK4, suppresses peritoneal metastases of gastric cancer in nude mice.
Ueda K; Iwahashi M; Matsuura I; Nakamori M; Nakamura M; Ojima T; Naka T; Ishida K; Matsumoto K; Nakamura T; Yamaue H
Eur J Cancer; 2004 Sep; 40(14):2135-42. PubMed ID: 15341989
[TBL] [Abstract][Full Text] [Related]
19. Reduced HGF expression in subcutaneous CT26 tumor genetically modified to secrete NK4 and its possible relation with antitumor effects.
Kubota T; Fujiwara H; Amaike H; Takashima K; Inada S; Atsuji K; Yoshimura M; Matsumoto K; Nakamura T; Yamagishi H
Cancer Sci; 2004 Apr; 95(4):321-7. PubMed ID: 15072590
[TBL] [Abstract][Full Text] [Related]
20. Chemotherapeutic agents potentiate adenoviral gene therapy for pancreatic cancer.
Egami T; Ohuchida K; Miyoshi K; Mizumoto K; Onimaru M; Toma H; Sato N; Matsumoto K; Tanaka M
Cancer Sci; 2009 Apr; 100(4):722-9. PubMed ID: 19302285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
